Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules.
Saleh A AlmatroodiAhmad Abdulaziz A AlmatroudiHajed Obaid A AlharbiAmjad Ali KhanArshad Husain RahmaniPublished in: Molecules (Basel, Switzerland) (2024)
Luteolin, a flavonoid, is mainly found in various vegetables and fruits, including carrots, cabbages, onions, parsley, apples, broccoli, and peppers. Extensive research in vivo and in vitro has been performed to explore its role in disease prevention and treatment. Moreover, this compound possesses the ability to combat cancer by modulating cell-signaling pathways across various types of cancer. The studies have confirmed that luteolin can inhibit cancer-cell survival and proliferation, angiogenesis, invasion, metastasis, mTOR/PI3K/Akt, STAT3, Wnt/β-catenin, and cell-cycle arrest, and induce apoptosis. Further, scientific evidence describes that this compound plays a vital role in the up/down-regulation of microRNAs (miRNAs) in cancer therapy. This review aims to outline the anti-cancer mechanisms of this compound and its molecular targets. However, a knowledge gap remains regarding the studies on its safety and efficacy and clinical trials. Therefore, it is essential to conduct more research based on safety, efficacy, and clinical trials to explore the beneficial role of this compound in disease management, including cancer.
Keyphrases
- pi k akt
- cell cycle arrest
- signaling pathway
- papillary thyroid
- clinical trial
- cell proliferation
- squamous cell
- cell death
- oxidative stress
- cancer therapy
- healthcare
- stem cells
- epithelial mesenchymal transition
- single cell
- lymph node metastasis
- childhood cancer
- open label
- squamous cell carcinoma
- mesenchymal stem cells
- risk assessment
- endothelial cells
- cell therapy
- randomized controlled trial
- endoplasmic reticulum stress
- climate change
- study protocol
- cell wall
- wound healing
- replacement therapy
- human health